Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.


CDC Resources: Pediatrics

SCCM’s COVID-19 Rapid Resource Center now links to pertinent content from the Centers for Disease Control and Prevention (CDC). These resources are categorized as Pediatrics

The information provided is for educational purposes for SCCM members and the general public. Clicking on these links allows users to leave www.sccm.org. The Society does not control the linked sites or the content on those sites. SCCM does not assume any liability for the content or information contained on these linked sites. Further, SCCM does not assume any liability or warrant with respect to the quality, noninfringement, accuracy, completeness, timeliness, or reliability of such linked sites. You should be aware that other internet sites that link to the Site may contain privacy provisions that differ from these policies. To ensure that your privacy is protected, we recommend that you review the privacy policies of other internet sites you visit.

Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022
Date Added: 5/19/2022
During the period of Omicron predominance (December 19, 2021–February 28, 2022), COVID-19–associated hospitalization rates in children aged 5–11 years were approximately twice as high among unvaccinated as among vaccinated children. Non-Hispanic Black children represented the largest group of unvaccinated children. Thirty percent of hospitalized children had no underlying medical conditions, and 19% were admitted to an intensive care unit. Children with diabetes and obesity were more likely to experience severe COVID-19.

Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022
Date Added: 3/31/2022
COVID-19 can cause severe illness in infants and children, including those aged 0–4 years who are not yet eligible for COVID-19 vaccination.
 
What is added by this report?
During Omicron variant predominance beginning in late December 2021, U.S. infants and children aged 0–4 years were hospitalized at approximately five times the rate of the previous peak during Delta variant predominance. Infants aged <6 months had the highest rates of hospitalization, but indicators of severity (e.g., respiratory support) did not differ by age group.

Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, July 2021–January 2022
Date Added: 2/23/2022
COVID-19 can cause severe illness in children and adolescents. Coinciding with increased circulation of the Omicron variant, COVID-19–associated hospitalization rates among children and adolescents aged 0–17 years increased rapidly in late December 2021, especially among children aged 0–4 years who are not yet eligible for vaccination. Throughout the periods of Delta and Omicron predominance, hospitalization rates remained lower among fully vaccinated adolescents aged 12–17 years than among unvaccinated adolescents.

COVID-19 Updates: What Clinicians Need to Know About Multisystem Inflammatory Syndrome in Children (Webinar)
Date Added: 2/16/2022
Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe condition associated with SARS-CoV-2 infection. The Centers for Disease Control and Prevention (CDC) has been actively involved in MIS-C surveillance and research, and development of MIS-C resources to support the public health and healthcare community. During this COCA Call, presenters will discuss CDC’s surveillance of MIS-C, updated MIS-C resources for healthcare providers, research that informed those resources, and data related to COVID-19 vaccination and MIS-C.

Pediatric COVID-19 Vaccines: CDC’s Recommendations for Pfizer-BioNTech COVID-19 Vaccine Primary Series in Children 5–11 Years Old
Date Added: 11/15/2021
COCA Call: Pediatric COVID-19 Vaccines: CDC’s Recommendations for Pfizer-BioNTech COVID-19 Vaccine Primary Series in Children 5–11 Years Old — During this COCA call, CDC provided an overview of its recommendations and clinical considerations for administering the Pfizer-BioNTech COVID-19 vaccination primary series in children aged 5–11 years old.
 
COVID-19 Vaccination for Children 5 through 11 Years Old
Date Added: 11/15/2021
Planning for COVID-19 Vaccination for Children 5 – 11 Years Old — The federal government is committed to ensuring children age 5 through 11 have access to COVID-19 vaccines if authorized by the U.S. Food and Drug Administration (FDA) and recommended by CDC’s Advisory Committee on Immunization Practices (ACIP). CDC has developed planning resources for jurisdictions, healthcare providers, pharmacists and community partners.
 
COVID-19 Trends Among Persons Aged 0–24 Years 
Date Added: 2/3/2021
This is a link to the CDC external resources regarding COVID-19 trends among persons aged 0–24 years.
 
Health Department-Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) in the United States ‚Äč
Date Added: 12/14/2020
Since mid-May 2020, CDC has been tracking reports of multisystem inflammatory syndrome in children (MIS-C), a rare but serious condition associated with COVID-19. MIS-C is a new syndrome, and many questions remain about why some children and adolescents develop it after a COVID-19 illness or contact with someone with COVID-19, while others do not.


Estimated Time:

Categories: Pediatrics, Crisis Management,
Content Type: External Resource,